Assessing cardiovascular risk knowledge in chronic kidney disease patients
Official title: Investigation of Knowledge of Cardiovascular Risk Factors and Perception of Benefits and Barriers to Exercise in Patients with Chronic Kidney Disease
Run by Hacettepe University · NCT06674031 · Data updated 2026-11-12
This study is trying to see how well people with chronic kidney disease understand heart health risks compared to healthy people, while also looking at their exercise habits and knowledge about staying active.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | November 6, 2024 |
| Main results expected | February 2025 |
| Study ends | May 2025 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06674031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-65 who have been diagnosed with chronic kidney disease.
✕Probably not a fit
Patients with cognitive problems or those who are illiterate may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the understanding of cardiovascular risk factors among patients with chronic kidney disease (CKD) compared to healthy individuals. It will also assess physical activity levels, health literacy, and perceptions regarding the benefits and barriers to exercise in this population. By gathering this information, the study seeks to identify gaps in knowledge and areas for potential intervention to improve health outcomes for CKD patients.
Why it matters
Potential benefit: If successful, this study could enhance patient education and promote healthier lifestyle choices among individuals with chronic kidney disease.
How similar studies have gone: While similar studies have explored health literacy and risk factor awareness in various populations, this specific focus on CKD patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with chronic kidney disease * Being aged 18-65 * Voluntary participation in the study Exclusion Criteria: * Having cognitive problems * Being illiterate
Where it's running
-
Hacettepe University
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Merve Firat
- Email: mervefirat@ahievran.edu.tr
- Phone: +90 850 441 02 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pilates exercises to improve balance, fatigue, and quality of life after kidney transplant
This study tests whether adding Pilates to standard physical therapy helps people aged 20–50 after a kidney transplant feel steadier, less fatigued, and have a better quality of life.
-
Transversalis fascia plane block to reduce pain after kidney transplant
See if a transversalis fascia plane block can reduce pain and opioid use after kidney transplant for adults aged 18–65 with ASA III.
-
Preoperative sensory modulation room to reduce pain, anxiety, and improve sleep for living kidney donors and recipients
The team will try a short preoperative session in a sensory modulation room to see if it lowers postoperative pain, reduces anxiety, and improves sleep for adult living kidney donors and transplant recipients.
-
Emotion-focused therapy to improve emotion regulation and well-being after kidney transplant
This project will try an emotion-focused therapy to see if it helps adults who have had a kidney transplant manage their emotions and feel better.
-
Biomarker-guided treatment strategy for chronic kidney disease
This trial will test whether using urine biomarkers to guide adding dapagliflozin, finerenone, and/or semaglutide can better reduce albuminuria and protect kidneys in adults with CKD.
-
Algae supplements for heart risk markers and gut health
This trial will test whether daily supplements of spirulina or Gelidium corneum change gut microbes and improve heart‑disease risk markers in adults over 50 with cardiovascular disease, diabetes, or related conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.